ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 114 filers reported holding ATHIRA PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,672 | -31.5% | 33,501 | 0.0% | 0.01% | -22.2% |
Q2 2023 | $98,828 | +18.0% | 33,501 | 0.0% | 0.01% | +28.6% |
Q1 2023 | $83,753 | -21.1% | 33,501 | 0.0% | 0.01% | -22.2% |
Q4 2022 | $106,198 | +7.3% | 33,501 | +0.0% | 0.01% | 0.0% |
Q3 2022 | $99,000 | -2.9% | 33,500 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $102,000 | -77.4% | 33,500 | 0.0% | 0.01% | -73.5% |
Q1 2022 | $452,000 | +26.3% | 33,500 | +21.8% | 0.03% | +30.8% |
Q4 2021 | $358,000 | – | 27,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |